Affymax (AFFY)
Add to Watchlists Create an Alert
1.40
+0.00 +0.00%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
Affymax Return on Equity:
-135.0% for Dec. 31, 2012Affymax Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -135.0% |
| Sept. 30, 2012 | -61.94% |
| June 30, 2012 | -40.90% |
| March 31, 2012 | -19.47% |
| Dec. 31, 2011 | -63.65% |
| Sept. 30, 2011 | -45.09% |
| June 30, 2011 | -49.32% |
| March 31, 2011 | -19.07% |
| Dec. 31, 2010 | -19.49% |
| Sept. 30, 2010 | -29.56% |
| June 30, 2010 | -52.12% |
| March 31, 2010 | -183.6% |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
AFFY Return on Equity Benchmarks
| Companies | |
|---|---|
| Amgen | 23.79% |
| Cytokinetics | -63.12% |
| Dendreon | -212.3% |
AFFY Return on Equity Rankings
| Overall |
44th percentile 4454 of 8006 |
| Sector |
34th percentile 449 of 686 in Healthcare |
| Industry |
45th percentile 136 of 248 in Biotechnology |
AFFY Return on Equity Range, Past 5 Years
| Minimum | -532.6% | Sep 2009 |
| Maximum | -19.07% | Mar 2011 |
| Average | -132.0% |
